Media Coverage

Media articles featuring INFORMS members in the news.

Most Recent Media Coverage

Topic
Europe Threatens to Restrict Vaccine Exports After AstraZeneca and Pfizer Hit Production Problems

Europe Threatens to Restrict Vaccine Exports After AstraZeneca and Pfizer Hit Production Problems

CNN Business, January 26, 2021

The European Union is calling out vaccine makers AstraZeneca (AZN) and Pfizer (PFE) over delivery delays that could slow its recovery from the pandemic. Officials are even threatening to restrict exports and take legal action as anger mounts. AstraZeneca will not be able to deliver as many doses of its vaccine as promised, according to EU officials, putting government rollout plans and the economic recovery at risk. The news comes after Pfizer said it had delivered fewer doses of its vaccine than expected last week. EU Health Commissioner Stella Kyriakides on Monday expressed dissatisfaction on talks with AstraZeneca and said conversations would continue. She said the drugmaker "intends to supply considerably fewer doses in the coming weeks than agreed and announced."

Houston Residents Worry About Where, When to Receive Their Second Vaccine Doses

Houston Residents Worry About Where, When to Receive Their Second Vaccine Doses

Houston Chronicle, January 26, 2021

Three weeks ago, Jim Lober became one of the lucky few to receive a first dose of the Moderna COVID-19 vaccine at Bayou City Event Center. Lober, a 69-year-old attorney, left the venue where thousands would wait in lines wrapping around the building with the beige card indicating he’d received the vaccine on Jan. 8 and was due back in four weeks for the final shot. At first, the Houston Health Department told him to call back the week before his second shot; but when he checked the city’s website, he learned he should wait for the department to reach out to him for scheduling. Now, with one week left before Lober should receive the second dose of Moderna, he has no clue when or where to go.

Biden Aims to Boost Covid-19 Vaccine Distribution by Using 1950s Law

Biden Aims to Boost Covid-19 Vaccine Distribution by Using 1950s Law

The Wall Street Journal, January 22, 2021

President Biden’s plan to use a Cold War-era law to boost the Covid-19 vaccination effort isn’t likely to expand production significantly in the near term, but it could jump-start vaccinations by increasing other supplies such as syringes, vaccine manufacturers and experts say. Mr. Biden has invoked the Defense Production Act to take certain steps to expand vaccine manufacturing, such as producing more equipment and materials used to make shots. He also will use the act to boost supplies such as “low dead space” syringes, which can be used to squeeze more doses out of vaccine vials. Mr. Biden, inaugurated Wednesday, has set a plan to administer 100 million vaccine doses in the first 100 days of his presidency.

Corporations Offer to Help With Vaccine Rollout

Corporations Offer to Help With Vaccine Rollout

Marketplace, January 22, 2021

The Donald Trump administration left the vaccine rollout, for the most part, to state and local governments. So right now, “it’s literally the Wild West,” said Anna Nagurney, professor of operations management at the University of Massachusetts Amherst. “You need better coordination, better communication and emphasizing operational efficiency,” Nagurney said. “And we know how to do that.” By “we,” she meant American companies.

How the U.S. Could Double the Vaccination Pace With Existing Supply

How the U.S. Could Double the Vaccination Pace With Existing Supply

The New York Times, January 22, 2021

President Biden’s promise to administer 100 million vaccines by his 100th day in office is no longer a lofty goal; it is attainable at the current pace at which shots are going into arms. In fact, some experts have suggested that the president’s ambition is far too modest. Federal data shows that the United States is already administering about one million doses a day, and even doubling that rate would not cause the country to fall short of distribution capacity or supply. Here’s how the vaccination campaign could play out if the United States maintains the current pace, assuming that the vaccine makers Pfizer-BioNTech and Moderna meet their supply agreements and vaccines continue to be distributed at the same rate they have been over the last two weeks.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Artificial Intelligence

The Stargate AI Project: America’s $500 Billion Bet - But at What Cost?

The Stargate AI Project: America’s $500 Billion Bet - But at What Cost?

The Fast Mode, February 10, 2025

The telecom industry is at a pivotal crossroads, and the only choice forward for telcos is to pursue innovation without the fear of failure. Telcos must be willing to capitalize on emerging technologies and shifting market dynamics that will soon dominate the future telecom landscape. Three areas, in particular, telcos should begin investing in and exploring (if they haven’t already) include:

Healthcare

We all benefit from and are hurt by health insurance claim denials

We all benefit from and are hurt by health insurance claim denials

Atlanta Journal Constitution, January 23, 2025

Health insurance has become necessary, with large and unpredictable health care costs always looming before each of us. Unfortunately, the majority of people have experienced problems when using their health insurance to pay for their medical care. Health insurance serves as the buffer between patients and the medical care system, using population pooling to mitigate the risk exposure on any one individual.

Supply Chain

Issues And Ideas With Chris DeBello

Issues And Ideas With Chris DeBello

Issues And Ideas With Chris DeBello, February 28, 2025

Prof. Anna Nagurney explains what Rare Earth Minerals are and their importance in a variety of industries along with day-to-day life

Climate